Partial-onset Seizures
📧 Sign up to get email alerts when something new happens for Partial-onset Seizures.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2022-03-17FDA Approved: LACOSAMIDE — Original Application (Glenmark Pharmaceuticals Inc. USA)
The FDA approved Glenmark’s lacosamide as an original generic drug application (ANDA); lacosamide is an anticonvulsant used to treat partial…
-
FDA approval · 2022-03-17FDA Approved: LACOSAMIDE — Original Application (Tris Pharma Inc)
FDA approved lacosamide from Tris Pharma Inc as an original generic drug application (ANDA 208308).
-
FDA approval · 2022-03-17FDA Approved: LACOSAMIDE — Original Application (Amneal Pharmaceuticals of New York LLC)
FDA approved lacosamide as an original application (ANDA) for Amneal Pharmaceuticals of New York LLC, making a generic lacosamide available …
-
FDA approval · 2022-03-08FDA Approved: PREGABALIN — Original Application (Eskayef Pharmaceuticals Limited)
FDA approved Eskayef Pharmaceuticals Limited's original application for generic pregabalin (ANDA212988).
-
FDA approval · 2022-02-18FDA Approved: PREGABALIN — Original Application (Patrin Pharma, Inc.)
FDA approved an original application for pregabalin from Patrin Pharma, making a generic version available. This marks the approval of a gen…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2022-01-11FDA Approved: OXCARBAZEPINE — Original Application (Camber Pharmaceuticals, Inc.)
FDA approved Camber Pharmaceuticals' original ANDA for oxcarbazepine, a generic anticonvulsant indicated for partial seizures.
-
FDA approval · 2021-10-14FDA Approved: VIMPAT — Supplemental Application (UCB, Inc.)
The FDA approved a supplemental application for VIMPAT (lacosamide) from UCB, Inc., to expand its approved indications for epilepsy.
-
FDA approval · 2021-09-15FDA Approved: VIMPAT — Supplemental Application (UCB, Inc.)
The FDA approved a supplemental application for Vimpat (lacosamide) by UCB, Inc.
-
FDA approval · 2021-09-15FDA Approved: VIMPAT — Supplemental Application (UCB, Inc.)
The FDA approved a supplemental application for VIMPAT (lacosamide) submitted by UCB, Inc. The approval pertains to changes to the drug's la…
-
FDA approval · 2021-09-02FDA Approved: BRIVIACT — Supplemental Application (UCB, Inc.)
FDA approved a supplemental application for BRIVIACT (brivaracetam) filed by UCB, Inc. The approval confirms modifications to the drug's lab…
-
FDA approval · 2021-08-27FDA Approved: BRIVIACT — Supplemental Application (UCB, Inc.)
The FDA approved a supplemental application for Briviact (brivaracetam) submitted by UCB, Inc. The approval updates Briviact's labeling and/…
-
FDA approval · 2021-07-15FDA Approved: PREGABALIN — Original Application (Tris Pharma Inc)
The FDA approved Tris Pharma's original Abbreviated New Drug Application for pregabalin, allowing a generic pregabalin product to enter the …
-
FDA approval · 2021-06-29FDA Approved: ESLICARBAZEPINE ACETATE — Original Application (Dr.Reddys Laboratories Inc)
FDA approved a generic eslicarbazepine acetate through an Original Application for Dr. Reddy's Laboratories, providing a generic option for …
-
FDA approval · 2021-06-11FDA Approved: LEVETIRACETAM — Original Application (ScieGen Pharmaceuticals, Inc.)
FDA approved the original application (ANDA) for LEVETIRACETAM by ScieGen Pharmaceuticals, authorizing the generic product.
-
FDA approval · 2021-04-13FDA Approved: PREGABALIN — Original Application (Novadoz Pharmaceuticals LLC)
FDA approves the original abbreviated new drug application for pregabalin from Novadoz Pharmaceuticals LLC, enabling a generic version of pr…
-
FDA approval · 2021-01-26FDA Approved: ZONISAMIDE — Original Application (Unichem Pharmaceuticals (USA), Inc.)
FDA approved Unichem Pharmaceuticals (USA), Inc.'s generic zonisamide product through an Abbreviated New Drug Application, confirming a gene…
-
FDA approval · 2021-01-19FDA Approved: LEVETIRACETAM — Supplemental Application (Prasco Laboratories)
FDA approved a supplemental application for LEVETIRACETAM filed by Prasco Laboratories.
-
FDA approval · 2020-11-27FDA Approved: LEVETIRACETAM ER — Original Application (Westminster Pharmaceuticals, LLC)
FDA approved Westminster Pharmaceuticals' generic extended-release levetiracetam tablet (LEVETIRACETAM ER) under an Original Abbreviated New…
-
FDA approval · 2020-11-05FDA Approved: OXCARBAZEPINE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved a supplemental application for oxcarbazepine from Sun Pharmaceutical Industries, Inc., resulting in an approved labeling change…
-
FDA approval · 2020-09-30FDA Approved: KEPPRA XR — Supplemental Application (UCB, Inc.)
FDA approved a supplemental application for KEPPRA XR (levetiracetam), the extended-release formulation, submitted by UCB, Inc.
-
FDA approval · 2020-08-26FDA Approved: OXCARBAZEPINE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
The FDA approved a supplemental application for oxcarbazepine filed by Sun Pharmaceutical Industries, Inc. (ANDA077794).
-
FDA approval · 2020-06-11FDA Approved: LEVETIRACETAM EXTENDED-RELEASE — Original Application (Omnivium Pharmaceuticals LLC)
FDA approved an extended-release generic formulation of levetiracetam (ANDA212688) manufactured by Omnivium Pharmaceuticals LLC.
-
FDA approval · 2020-04-03FDA Approved: LYRICA CR — Supplemental Application (Viatris Specialty LLC)
FDA approved a supplemental NDA for LYRICA CR (pregabalin) submitted by Viatris Specialty LLC, indicating a regulatory approval of a supplem…
-
FDA approval · 2020-03-23FDA Approved: PREGABALIN — Original Application (Creekwood Pharmaceuticals LLC)
FDA approves Creekwood Pharmaceuticals LLC's Original Application (ANDA) for pregabalin, enabling a generic version of the drug. This action…
-
FDA approval · 2019-11-29FDA Approved: PREGABALIN — Original Application (Sun Pharmaceutical Industries, Inc.)
FDA approved the original ANDA for pregabalin from Sun Pharmaceutical Industries, authorizing a generic version of pregabalin.